Patent · US Active

Engineered enzymes

US10876102B2 · kind B2 · utility

7Cited by
16References
23Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 9, 2020
Grant dateDec 29, 2020
Priority date—
Expiry dateApr 9, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N9/22
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present disclosure provides engineered RNA-guided enzymes for editing live cells.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.